Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Access to Care and Drug Prices: Recent Department of Health and Human Services Guidance.
Journal: Oncology (Williston Park, N.Y.)
Published: July 31, 2026
Access to Care and the Affordable Care Act: Why Do Problems Exist 15 Years Later?
Journal: Oncology (Williston Park, N.Y.)
Published: May 05, 2026
Plain language summary: Does the amount of time it takes for prostate-specific antigen to double affect how long men with nonmetastatic castration-resistant prostate cancer live and their healthcare costs?
Journal: Future oncology (London, England)
Published: August 30, 2023
External control arms: COVID-19 reveals the merits of using real world evidence in real-time for clinical and public health investigations.
Journal: Frontiers in medicine
Published: March 31, 2023
Does race make a difference in how long men with advanced prostate cancer live when treated with abiraterone or enzalutamide?
Journal: Future oncology (London, England)
Published: October 13, 2022
Survival and Economic Impact of Rapid Prostate-Specific Antigen Doubling Time in Patients With Nonmetastatic Castration-Resistant Prostate Cancer.
Journal: Clinical genitourinary cancer
Published: September 12, 2022
Academic Promotion and Oncology Drug Development: Role, Responsibilities, and Integrity
Journal: Oncology (Williston Park, N.Y.)
Published: February 18, 2022
Clinical and economic burden of HPV-related cancers in the US veteran population.
Journal: Journal of medical economics
Published: February 14, 2022
COVID-19 associated disruptions in routine health care of people with mild cognitive impairment or dementia.
Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: December 08, 2021
Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017.
Journal: The oncologist
Published: November 05, 2021
Survival by race in men with chemotherapy-naive enzalutamide- or abiraterone-treated metastatic castration-resistant prostate cancer.
Journal: Prostate cancer and prostatic diseases
Published: April 21, 2021
Time to Next Treatment, Health Care Resource Utilization, and Costs Associated with Ibrutinib Use Among U.S. Veterans with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Real-World Retrospective Analysis.
Journal: Journal of managed care & specialty pharmacy
Published: September 04, 2020
Last Updated: 09/26/2026